Intuitive Surgical Inc

ISRG: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$411.00YddPtbsnymmf

Procedures Growth Remains Robust Across the Board for Intuitive Surgical

Business Strategy and Outlook

Intuitive Surgical fared remarkably well during the pandemic even as many hospitals struggled with tight capital budgets and elective surgeries were almost nonexistent during the COVID-19 peak. Now, with things returning to normal, the company is set to resume its march toward global adoption of robotic surgery. Our long-term positive view on the company's competitive positioning is unchanged, even as new rivals are entering the previously monopolistic area of robot-assisted surgery.

Sponsor Center